Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence GPPPPPGKPQ
Primary information
sequence IDSeq_3029
Peptide sequenceGPPPPPGKPQ
CancerPDF_ID CancerPDF_ID3866, CancerPDF_ID3867, CancerPDF_ID3868, CancerPDF_ID3885, CancerPDF_ID3886, CancerPDF_ID3887, CancerPDF_ID3907, CancerPDF_ID3908, CancerPDF_ID3909, CancerPDF_ID3910, CancerPDF_ID13496,
PMID22809520,22809520,22809520,22809520,22809520,22809520,22809520,22809520,22809520,22809520,20974924
Protein NameBasic PRP1 (Basic salivary proline-rich protein 1),Basic PRP1 (Basic salivary proline-rich protein 1),Basic PRP1 (Basic salivary proline-rich protein 1),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic PRP2 (Basic salivary proline-rich protein 2),Basic salivary proline-rich protein 2
UniprotKB Entry NamePRP1_HUMAN,PRP1_HUMAN,PRP1_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRPC_HUMAN,PRB2_HUMAN
FluidSaliva,Saliva,Saliva,Saliva,Saliva,Saliva,Saliva,Saliva,Saliva,Saliva,Plasma
M/ZNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,971.531
ChargeNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2
Mass (in Da)NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
fdr1275.74,1579.94,1317.75,1317.75,1318.74,1275.74,1317.75,1318.74,1579.94,1275.74,NA
Profiling TechniqueLC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS and iTRAQ,LC-MS
Peptide Identification techniqueMS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,LC-MS/MS
Quantification Technique"2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay","2,4,6-trinitrobenzenesulfonic acid assay",NA
Labelled/Label FreeLabelled,Labelled,Labelled,Labelled,Labelled,Labelled,Labelled,Labelled,Labelled,Labelled,Label Free
FDRNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CancerPDF_ID CancerPDF_ID3866, CancerPDF_ID3867, CancerPDF_ID3868, CancerPDF_ID3885, CancerPDF_ID3886, CancerPDF_ID3887, CancerPDF_ID3907, CancerPDF_ID3908, CancerPDF_ID3909, CancerPDF_ID3910, CancerPDF_ID13496,
p-ValueNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
SoftwareMASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT (v2.1.1),MASCOT and SEQUEST
Length10,10,10,10,10,10,10,10,10,10,NA
Cancer TypeNormal,Normal,Normal,Normal,Normal,Normal,Normal,Normal,Normal,Normal,"Multiple myeloma patients, Acute myeloid leukemia"
DatabaseSwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),SwissProt Database (release date 010111),Uniprot database
ModificationiTRAQ8plex at N-term; iTRAQ8plex(K) at 8,iTRAQ8plex at N-term; iTRAQ8plex(K) at 8,iTRAQ8plex at N-term; iTRAQ8plex(K) at 8,AcetylatN-term; iTRAQ8plex(K)at8,CarbamylatN-term; iTRAQ8plex(K)at8,iTRAQ8plexatN-term; iTRAQ8plex(K)at8,NA,NA,NA,NA,NA
Number of PatientsNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
RegulationNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
ValidationNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
SensitivityNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
SpecificityNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
AccuracyNA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Peptide AtlasNA
IEDB437706